Results 91 to 100 of about 326,396 (335)
Advances in Cancer Immunotherapy for Solid Tumors
Cancer immunotherapy for solid tumors is rapidly evolving beyond classical checkpoint blockade toward more precise strategies. Emerging checkpoint targets, bispecific antibodies, antibody–drug conjugate combinations, personalized vaccines, cellular therapies, and engineered cytokines are expanding therapeutic possibilities, while biomarker‐guided ...
Shira Gabizon‐Peretz +1 more
wiley +1 more source
Semi-quantitative CT severity scoring as a predictor of development of post-COVID syndrome
Background Following COVID-19 pandemic, clinical description focused on the clinical presentation of patients in the acute stage of the disease. More recently, data have emerged that some patients continue to experience symptoms related to COVID-19 after
Mohammad A. Saad +3 more
doaj +1 more source
International audienceInfection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the coronavirus disease 2019 (COVID-19) pandemic that has resulted in millions of deaths and a major strain on health systems worldwide ...
Monnet, Xavier +15 more
core +1 more source
Unlike deceased‐donor liver transplantation, living‐donor liver transplantation (LDLT) for Budd‐Chiari Syndrome (BCS) presents distinctive challenges in hepatic venous (HV)‐outflow reconstruction because diseased HV–inferior vena cava (IVC) cannot be entirely replaced with healthy donor vessels.
Koichiro Hata +4 more
wiley +1 more source
What is the impact of post-COVID-19 syndrome on health-related quality of life and associated factors: a cross-sectional analysis [PDF]
Ilaria Mastrorosa +15 more
openalex +1 more source
Supplemental Material, sj-pdf-1-cns-10.1177_11795735221102727 for Fatigue in Post-COVID-19 Syndrome: Clinical Phenomenology, Comorbidities and Association With Initial Course of COVID-19 by Lara Diem, LiviaFregolente-Gomes, Jan D.
Manuela Funke-Chambour (4590088) +12 more
core +1 more source
ABSTRACT Management of cerebral vasculopathy in sickle cell anemia (SCA) includes standard‐care, that is, chronic transfusion (CT) or hydroxyurea, and hematopoietic cell transplantation (HCT). DREPAGREFFE‐1 (December 2010/June 2013), a French multicenter trial, was the first prospective trial comparing standard‐care to match sibling donor (MSD)‐HCT in ...
Francoise Bernaudin +40 more
wiley +1 more source
Multivariable regression model analyzing potential risk factors for post-COVID-19 syndrome.
Multivariable regression model analyzing potential risk factors for post-COVID-19 syndrome.
Maciej Debski (10589812) +9 more
core +1 more source
Covid-19 Cytokine Release Syndrome and Drugs [PDF]
A survey of literature about the Cytokine Release Syndrome in Covid-19 and of some drugs used or proposed against ...
Sparavigna, Amelia Carolina +1 more
core +1 more source
ABSTRACT Autosomal recessive loss‐of‐function variants in PPP1R13L cause an ultra‐rare cardiocutaneous syndrome characterized by rapidly progressive arrhythmogenic cardiomyopathy (ACM). PPP1R13L encodes iASPP, which has two potentially overlapping mechanisms driving ACM as both a regulator of NFκB‐mediated inflammation and a binding partner within the ...
Aaron Renberg +9 more
wiley +1 more source

